Global Cancer (Tumor) Profiling Supply, Demand and Key Producers, 2024-2030

Description

The global Cancer (Tumor) Profiling market size is expected to reach $ 19440 million by 2030, rising at a market growth of 10.7% CAGR during the forecast period (2024-2030).

Surging cancer prevalence across the globe is one of the major factors contributing to the market growth. Cancer is the second leading cause of death worldwide. One in six deaths worldwide is due to cancer. In middle- and lower-class economies, 70% of deaths are due to cancer. This expands the growth scope of the market. Surging public-private funding of targeted research activities, emergence of cancer profiling relative to traditional methods of cancer diagnosis, increasing geriatric population base, and increasing product innovation and development due to technological advancements across the world will provide lucrative opportunities for market players. Estimated period 2022-2029. In addition, the surge in the number of strategic cooperations, rising Internet penetration, increasing number of hospitals and laboratories, increasing cases of lung cancer, prostate cancer, and acute leukemia, and increasing healthcare expenditure per capita will lead to further expansion of the market growth rate in the future.

Cancer(tumor) profiling is the technology oncologists use to determine if the pathways of a patient's tumor match up with available targeted treatments. Tumor profiling starts with obtaining a sample of tumor tissue. The tissue is usually collected through a core biopsy, but it can also be taken during surgery.

This report studies the global Cancer (Tumor) Profiling demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer (Tumor) Profiling, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer (Tumor) Profiling that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer (Tumor) Profiling total market, 2019-2030, (USD Million)
Global Cancer (Tumor) Profiling total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cancer (Tumor) Profiling total market, key domestic companies and share, (USD Million)
Global Cancer (Tumor) Profiling revenue by player and market share 2019-2024, (USD Million)
Global Cancer (Tumor) Profiling total market by Type, CAGR, 2019-2030, (USD Million)
Global Cancer (Tumor) Profiling total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cancer (Tumor) Profiling market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Qiagen, Neogenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics Corporation, Nanostring Technologies and Oxford Gene Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer (Tumor) Profiling market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cancer (Tumor) Profiling Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer (Tumor) Profiling Market, Segmentation by Type
    Immunoassay
    NGS
    Mass Spectrometry
    Others

Global Cancer (Tumor) Profiling Market, Segmentation by Application
    Clinical
    Research

Companies Profiled:
    Illumina
    Qiagen
    Neogenomics Laboratories
    HTG Molecular Diagnostics
    Genomic Health
    Caris Life Sciences
    Helomics Corporation
    Nanostring Technologies
    Oxford Gene Technology
    Ribomed Biotechnologies

Key Questions Answered
1. How big is the global Cancer (Tumor) Profiling market?
2. What is the demand of the global Cancer (Tumor) Profiling market?
3. What is the year over year growth of the global Cancer (Tumor) Profiling market?
4. What is the total value of the global Cancer (Tumor) Profiling market?
5. Who are the major players in the global Cancer (Tumor) Profiling market?

Table of Contents

1 Supply Summary
    1.1 Cancer (Tumor) Profiling Introduction
    1.2 World Cancer (Tumor) Profiling Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cancer (Tumor) Profiling Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer (Tumor) Profiling Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.3 China Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.4 Europe Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.5 Japan Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.6 South Korea Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.7 ASEAN Cancer (Tumor) Profiling Market Size (2019-2030)
        1.3.8 India Cancer (Tumor) Profiling Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer (Tumor) Profiling Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer (Tumor) Profiling Major Market Trends

2 Demand Summary
    2.1 World Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.2 World Cancer (Tumor) Profiling Consumption Value by Region
        2.2.1 World Cancer (Tumor) Profiling Consumption Value by Region (2019-2024)
        2.2.2 World Cancer (Tumor) Profiling Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.4 China Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.5 Europe Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.6 Japan Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.7 South Korea Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.8 ASEAN Cancer (Tumor) Profiling Consumption Value (2019-2030)
    2.9 India Cancer (Tumor) Profiling Consumption Value (2019-2030)

3 World Cancer (Tumor) Profiling Companies Competitive Analysis
    3.1 World Cancer (Tumor) Profiling Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer (Tumor) Profiling Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer (Tumor) Profiling in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cancer (Tumor) Profiling in 2023
    3.3 Cancer (Tumor) Profiling Company Evaluation Quadrant
    3.4 Cancer (Tumor) Profiling Market: Overall Company Footprint Analysis
        3.4.1 Cancer (Tumor) Profiling Market: Region Footprint
        3.4.2 Cancer (Tumor) Profiling Market: Company Product Type Footprint
        3.4.3 Cancer (Tumor) Profiling Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer (Tumor) Profiling Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer (Tumor) Profiling Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cancer (Tumor) Profiling Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cancer (Tumor) Profiling Consumption Value Comparison
        4.2.1 United States VS China: Cancer (Tumor) Profiling Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cancer (Tumor) Profiling Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cancer (Tumor) Profiling Companies and Market Share, 2019-2024
        4.3.1 United States Based Cancer (Tumor) Profiling Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024)
    4.4 China Based Companies Cancer (Tumor) Profiling Revenue and Market Share, 2019-2024
        4.4.1 China Based Cancer (Tumor) Profiling Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024)
    4.5 Rest of World Based Cancer (Tumor) Profiling Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cancer (Tumor) Profiling Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cancer (Tumor) Profiling Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Immunoassay
        5.2.2 NGS
        5.2.3 Mass Spectrometry
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Cancer (Tumor) Profiling Market Size by Type (2019-2024)
        5.3.2 World Cancer (Tumor) Profiling Market Size by Type (2025-2030)
        5.3.3 World Cancer (Tumor) Profiling Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cancer (Tumor) Profiling Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Clinical
        6.2.2 Research
    6.3 Market Segment by Application
        6.3.1 World Cancer (Tumor) Profiling Market Size by Application (2019-2024)
        6.3.2 World Cancer (Tumor) Profiling Market Size by Application (2025-2030)
        6.3.3 World Cancer (Tumor) Profiling Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Illumina
        7.1.1 Illumina Details
        7.1.2 Illumina Major Business
        7.1.3 Illumina Cancer (Tumor) Profiling Product and Services
        7.1.4 Illumina Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Illumina Recent Developments/Updates
        7.1.6 Illumina Competitive Strengths & Weaknesses
    7.2 Qiagen
        7.2.1 Qiagen Details
        7.2.2 Qiagen Major Business
        7.2.3 Qiagen Cancer (Tumor) Profiling Product and Services
        7.2.4 Qiagen Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Qiagen Recent Developments/Updates
        7.2.6 Qiagen Competitive Strengths & Weaknesses
    7.3 Neogenomics Laboratories
        7.3.1 Neogenomics Laboratories Details
        7.3.2 Neogenomics Laboratories Major Business
        7.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Product and Services
        7.3.4 Neogenomics Laboratories Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Neogenomics Laboratories Recent Developments/Updates
        7.3.6 Neogenomics Laboratories Competitive Strengths & Weaknesses
    7.4 HTG Molecular Diagnostics
        7.4.1 HTG Molecular Diagnostics Details
        7.4.2 HTG Molecular Diagnostics Major Business
        7.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Services
        7.4.4 HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 HTG Molecular Diagnostics Recent Developments/Updates
        7.4.6 HTG Molecular Diagnostics Competitive Strengths & Weaknesses
    7.5 Genomic Health
        7.5.1 Genomic Health Details
        7.5.2 Genomic Health Major Business
        7.5.3 Genomic Health Cancer (Tumor) Profiling Product and Services
        7.5.4 Genomic Health Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Genomic Health Recent Developments/Updates
        7.5.6 Genomic Health Competitive Strengths & Weaknesses
    7.6 Caris Life Sciences
        7.6.1 Caris Life Sciences Details
        7.6.2 Caris Life Sciences Major Business
        7.6.3 Caris Life Sciences Cancer (Tumor) Profiling Product and Services
        7.6.4 Caris Life Sciences Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Caris Life Sciences Recent Developments/Updates
        7.6.6 Caris Life Sciences Competitive Strengths & Weaknesses
    7.7 Helomics Corporation
        7.7.1 Helomics Corporation Details
        7.7.2 Helomics Corporation Major Business
        7.7.3 Helomics Corporation Cancer (Tumor) Profiling Product and Services
        7.7.4 Helomics Corporation Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Helomics Corporation Recent Developments/Updates
        7.7.6 Helomics Corporation Competitive Strengths & Weaknesses
    7.8 Nanostring Technologies
        7.8.1 Nanostring Technologies Details
        7.8.2 Nanostring Technologies Major Business
        7.8.3 Nanostring Technologies Cancer (Tumor) Profiling Product and Services
        7.8.4 Nanostring Technologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Nanostring Technologies Recent Developments/Updates
        7.8.6 Nanostring Technologies Competitive Strengths & Weaknesses
    7.9 Oxford Gene Technology
        7.9.1 Oxford Gene Technology Details
        7.9.2 Oxford Gene Technology Major Business
        7.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Product and Services
        7.9.4 Oxford Gene Technology Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Oxford Gene Technology Recent Developments/Updates
        7.9.6 Oxford Gene Technology Competitive Strengths & Weaknesses
    7.10 Ribomed Biotechnologies
        7.10.1 Ribomed Biotechnologies Details
        7.10.2 Ribomed Biotechnologies Major Business
        7.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Services
        7.10.4 Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Ribomed Biotechnologies Recent Developments/Updates
        7.10.6 Ribomed Biotechnologies Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer (Tumor) Profiling Industry Chain
    8.2 Cancer (Tumor) Profiling Upstream Analysis
    8.3 Cancer (Tumor) Profiling Midstream Analysis
    8.4 Cancer (Tumor) Profiling Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer (Tumor) Profiling Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer (Tumor) Profiling Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer (Tumor) Profiling Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer (Tumor) Profiling Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cancer (Tumor) Profiling Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer (Tumor) Profiling Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cancer (Tumor) Profiling Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cancer (Tumor) Profiling Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cancer (Tumor) Profiling Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer (Tumor) Profiling Players in 2023
    Table 12. World Cancer (Tumor) Profiling Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cancer (Tumor) Profiling Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer (Tumor) Profiling Player
    Table 15. Cancer (Tumor) Profiling Market: Company Product Type Footprint
    Table 16. Cancer (Tumor) Profiling Market: Company Product Application Footprint
    Table 17. Cancer (Tumor) Profiling Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer (Tumor) Profiling Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cancer (Tumor) Profiling Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cancer (Tumor) Profiling Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cancer (Tumor) Profiling Revenue Market Share (2019-2024)
    Table 23. China Based Cancer (Tumor) Profiling Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cancer (Tumor) Profiling Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cancer (Tumor) Profiling Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer (Tumor) Profiling Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cancer (Tumor) Profiling Revenue Market Share (2019-2024)
    Table 29. World Cancer (Tumor) Profiling Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cancer (Tumor) Profiling Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (USD Million)
    Table 35. Illumina Basic Information, Area Served and Competitors
    Table 36. Illumina Major Business
    Table 37. Illumina Cancer (Tumor) Profiling Product and Services
    Table 38. Illumina Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Illumina Recent Developments/Updates
    Table 40. Illumina Competitive Strengths & Weaknesses
    Table 41. Qiagen Basic Information, Area Served and Competitors
    Table 42. Qiagen Major Business
    Table 43. Qiagen Cancer (Tumor) Profiling Product and Services
    Table 44. Qiagen Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Qiagen Recent Developments/Updates
    Table 46. Qiagen Competitive Strengths & Weaknesses
    Table 47. Neogenomics Laboratories Basic Information, Area Served and Competitors
    Table 48. Neogenomics Laboratories Major Business
    Table 49. Neogenomics Laboratories Cancer (Tumor) Profiling Product and Services
    Table 50. Neogenomics Laboratories Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Neogenomics Laboratories Recent Developments/Updates
    Table 52. Neogenomics Laboratories Competitive Strengths & Weaknesses
    Table 53. HTG Molecular Diagnostics Basic Information, Area Served and Competitors
    Table 54. HTG Molecular Diagnostics Major Business
    Table 55. HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Services
    Table 56. HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. HTG Molecular Diagnostics Recent Developments/Updates
    Table 58. HTG Molecular Diagnostics Competitive Strengths & Weaknesses
    Table 59. Genomic Health Basic Information, Area Served and Competitors
    Table 60. Genomic Health Major Business
    Table 61. Genomic Health Cancer (Tumor) Profiling Product and Services
    Table 62. Genomic Health Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Genomic Health Recent Developments/Updates
    Table 64. Genomic Health Competitive Strengths & Weaknesses
    Table 65. Caris Life Sciences Basic Information, Area Served and Competitors
    Table 66. Caris Life Sciences Major Business
    Table 67. Caris Life Sciences Cancer (Tumor) Profiling Product and Services
    Table 68. Caris Life Sciences Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Caris Life Sciences Recent Developments/Updates
    Table 70. Caris Life Sciences Competitive Strengths & Weaknesses
    Table 71. Helomics Corporation Basic Information, Area Served and Competitors
    Table 72. Helomics Corporation Major Business
    Table 73. Helomics Corporation Cancer (Tumor) Profiling Product and Services
    Table 74. Helomics Corporation Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Helomics Corporation Recent Developments/Updates
    Table 76. Helomics Corporation Competitive Strengths & Weaknesses
    Table 77. Nanostring Technologies Basic Information, Area Served and Competitors
    Table 78. Nanostring Technologies Major Business
    Table 79. Nanostring Technologies Cancer (Tumor) Profiling Product and Services
    Table 80. Nanostring Technologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Nanostring Technologies Recent Developments/Updates
    Table 82. Nanostring Technologies Competitive Strengths & Weaknesses
    Table 83. Oxford Gene Technology Basic Information, Area Served and Competitors
    Table 84. Oxford Gene Technology Major Business
    Table 85. Oxford Gene Technology Cancer (Tumor) Profiling Product and Services
    Table 86. Oxford Gene Technology Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Oxford Gene Technology Recent Developments/Updates
    Table 88. Ribomed Biotechnologies Basic Information, Area Served and Competitors
    Table 89. Ribomed Biotechnologies Major Business
    Table 90. Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Services
    Table 91. Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 92. Global Key Players of Cancer (Tumor) Profiling Upstream (Raw Materials)
    Table 93. Cancer (Tumor) Profiling Typical Customers
List of Figure
    Figure 1. Cancer (Tumor) Profiling Picture
    Figure 2. World Cancer (Tumor) Profiling Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cancer (Tumor) Profiling Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cancer (Tumor) Profiling Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer (Tumor) Profiling Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cancer (Tumor) Profiling Revenue (2019-2030) & (USD Million)
    Figure 13. Cancer (Tumor) Profiling Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cancer (Tumor) Profiling Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cancer (Tumor) Profiling by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer (Tumor) Profiling Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer (Tumor) Profiling Markets in 2023
    Figure 27. United States VS China: Cancer (Tumor) Profiling Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cancer (Tumor) Profiling Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cancer (Tumor) Profiling Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cancer (Tumor) Profiling Market Size Market Share by Type in 2023
    Figure 31. Immunoassay
    Figure 32. NGS
    Figure 33. Mass Spectrometry
    Figure 34. Others
    Figure 35. World Cancer (Tumor) Profiling Market Size Market Share by Type (2019-2030)
    Figure 36. World Cancer (Tumor) Profiling Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Cancer (Tumor) Profiling Market Size Market Share by Application in 2023
    Figure 38. Clinical
    Figure 39. Research
    Figure 40. Cancer (Tumor) Profiling Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies